Skip to content
Revolution Medicines

Director, Analytical Development

Redwood City, California, United States; Redwood City, CAUnited States
Director+ · Analytical Development & Quality Control
POSTED 18 NOVVERIFIED 3M AGO
Apply Ask
Role
0 days opentrue age
Closes in ~42d at the median (42d)
Posted 18 Nov · n=33
Payats field
$211k–264kposted
▼ −5% vs market median $250k
$210k$289k
Market p25–p75
$210k–$289k
Revolution Medicines p25–p75
$226k–$275kn=68
SF Bay Area · n=1142 · 365d to 15 Nov
CompanyRevolution Medicines →
337open roles
Opened · 30d
+47
Closed · 30d
−31
12d of snapshots · 30d window
Market
25,413open · Director+ Other
Opened · 7d
+2,43610% of open
All other
621,449open
All tracked boards · live 18 Nov · n=25,413

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity

This leadership role will provide strategic and operational oversight for Analytical Development within the PDM organization, leading analytical strategies and execution to support Revolution Medicines’ pipeline and clinical programs. Responsibilities include oversight of analytical method development, validation, transfer, release and stability testing, regulatory support, and management of external partners to enable phase appropriate development and commercialization readiness.

Provide strategic and organizational leadership for analytical development activities supporting small molecule API and drug product development, including oversight of phase appropriate control strategies, specification setting, analytical lifecycle management, and overall CMC analytical strategy.

Lead and oversee analytical development execution across internal and external teams to support the development, characterization, and manufacturing of API and drug product, while actively contributing to cross functional PDM project teams.

Provide strategic guidance and oversight for regulatory submission activities, including authoring and review Quality sections of regulatory submissions, and leading responses to regulatory queries.

Establish and drive analytical strategies, technology selection, and operational execution through effective management of CDMOs, CROs, and contract laboratories, with accountability for quality, timelines, risk management, and delivery.

Provide leadership oversight for preparation, review, and approval of analytical protocols, reports, specifications, investigations, and technical documentation to ensure scientific excellence, regulatory compliance, and inspection readiness.

Build strong cross functional partnerships and influence across Drug Product, Drug Substance, Regulatory Affairs, QA, Project Management, Medicinal Chemistry, DMPK, Toxicology and senior leadership teams to drive strategic decision making and achievement of program and organizational goals.

Required Skills, Experience and Education

PhD preferred (minimum MS) in Analytical Chemistry, Organic Chemistry, or a related scientific discipline.

10+ years of progressive leadership experience in analytical development within the pharmaceutical or biotechnology industry.

Proven ability to lead cross functional teams, influence organizational decision making, and drive execution of complex development strategies in a matrix environment.

Extensive strategic and operational leadership experience overseeing analytical activities across small molecule drug development, with strong preference for late phase development, regulatory approval, and commercialization readiness.

Excellent communication, collaboration, people leadership, and stakeholder management skills.

Deep understanding of CMC strategies and analytical enablement for small molecule development programs.

Demonstrated leadership experience managing external partners, including CROs and CDMOs, to ensure high-quality deliverables and program execution.

Strong knowledge of global regulatory requirements and experience supporting regulatory submissions, including INDs, IMPDs, NDAs, and/or MAAs.

In-depth understanding of ICH guidelines, GMP regulations, and current industry best practices related to analytical development and quality.

Source · Revolution MedicinesFirst seen 18 NovOriginal ↗